Lynx1 Capital Management LP, 10% Owner at Passage BIO, Inc. (PASG), bought 747,290 shares at $0.65 ($486K) on 2024-12-27, disclosed to the SEC on 2024-12-31.
Open-market purchase of $486k PASG by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.65 | 373,645 | $243K | 50.0% |
| 2 | $0.65 | 373,645 | $243K | 50.0% |
| Total | $0.65 avg | 747,290 | $486K | 100% |
| Filing → |
| KRRO | BUY | 2026-04-02 | $6K | — | Filing → |
| TCRX | BUY | 2025-12-23 | $218K | — | Filing → |
| NEUP | BUY | 2025-10-23 | $6.6M | — | Filing → |